Additionally, higher TNFSF13 expression was relevant to worse progression-free survival (PFS) and disease-specific survival (DSS) in pan-gliomas, LGG, and GBM cohorts (Supplementary Figure S5). The gene discussed is TNFSF13; the disease is central nervous system cancer.